Radiotherapy is widely used in clinic due to its good effect for cancer treatment. But radiotherapy of malignant tumors in the abdomen and pelvis is easy to cause radiation enteritis complications. Gastrointestinal tract contains numerous microbes, most of which are mutualistic relationship with the host. Abdominal radiation results in gut microbiota dysbiosis. Microbial therapy can directly target gut microbiota to reverse microbiota dysbiosis, hence relieving intestinal inflammation. In this review, we mainly summarized pathogenesis and novel therapy of the radiation-induced intestinal injury with gut microbiota dysbiosis and envision the opportunities and challenges of radiation enteritis therapy.
Rationale: Fecal microbiota transplantation (FMT) is advantageous for treating intractable diseases via the microbiota-gut-organ axis. However, invasive administration of gut microbiota via nasal feeding tubes limits the widespread application of FMT. Here, we attempted to develop a novel strategy to deliver gut microbiota using nanocapsules.
This study introduces whole microbiota transplantation (WMT), a synergistic therapeutic approach that concurrently transplants small intestinal and fecal microbiota. In germ‐free mice, WMT outperforms conventional fecal microbiota transplantation (FMT) in restoring gut microbiota diversity and abundance. Moreover, in a chemotherapy‐induced intestinal mucositis model, WMT alleviates intestinal inflammation and reverses microbiota dysbiosis. Encapsulation in layer‐by‐layer self‐assembled nanocapsules further boosts microbial survival and colonization, amplifying WMT's anti‐inflammatory effects and microbiota restoration in a mouse model of pan‐intestinal infection. Overall, WMT represents a precise strategy for reshaping microbial homeostasis across the entire gastrointestinal tract, with therapeutic promise for inflammatory bowel diseases and small‐intestinal disorders.
Wound management remains a clinical challenge due to the complexity of healing processes. Traditional dressings with passive protection mechanisms and modern synthetic alternatives often fail to recapitulate the dynamic biological interactions in the wound microenvironment. Mucus is a naturally widely available biomaterial, exhibiting superior bioactive properties as a viscoelastic gel-like substance. Notably, natural mucus derived from diverse biological sources has garnered significant attention as advanced wound dressings. This review explores the potential of natural mucus from animals, plants, microorganisms, and other complex sources as multifunctional wound healing platforms. By analyzing the therapeutic effects of natural mucus, we evaluate its key molecular mechanisms and performance metrics against clinical wound dressings. This establishes a scientific framework for mucus-inspired biomaterials design. The comprehensive assessment not only reveals the untapped potential of renewable biological resources in developing eco-friendly, high-performance wound care alternatives but also provides theoretical guidance for developing next-generation dressings with bioactive, self-adaptive, and environmentally responsive characteristics.